Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma to the Liver”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Early research (Phase 1)Study completedNCT01839604
What this trial is testing

A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular CarcinomaHepatocellular Carcinoma Metastatic
AstraZeneca 58
Testing effectiveness (Phase 2)Looking for participantsNCT06860815
What this trial is testing

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Carcinoma in the Liver
City of Hope Medical Center 11
Not applicableWithdrawnNCT01847495
What this trial is testing

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis

Who this might be right for
Colorectal Cancer
Wake Forest University Health Sciences
Large-scale testing (Phase 3)UnknownNCT03500380
What this trial is testing

RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Who this might be right for
Breast NeoplasmsBreast DiseasesCapecitabine+3 more
RemeGen Co., Ltd. 301
Not applicableStudy completedNCT03301493
What this trial is testing

Genomic Testing and Resulting Medical Decisions

Who this might be right for
Cancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Not applicableStudy completedNCT01528878
What this trial is testing

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Who this might be right for
Liver NeoplasmsColonic NeoplasmsMetastatic Cancer to Liver
UNC Lineberger Comprehensive Cancer Center 30
Not applicableWithdrawnNCT05059717
What this trial is testing

An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases

Who this might be right for
Colorectal Carcinoma Metastatic in the Liver
M.D. Anderson Cancer Center
Early research (Phase 1)UnknownNCT05031949
What this trial is testing

Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Combinational ImmunotherapyHepatocellular Carcinoma Non-ResectableHyperbaric Oxygen Therapy
Zhang Bi Xiang, MD 20
Early research (Phase 1)UnknownNCT04612504
What this trial is testing

SynOV1.1 Intratumoral Injection Study

Who this might be right for
Hepatocellular Carcinoma
Beijing Syngentech Co., Ltd. 15
Not applicableLooking for participantsNCT07159048
What this trial is testing

The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors

Who this might be right for
Hepatocellular CarcinomaColorectal Cancer Liver Metastasis
Fudan University 120
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Not applicableStudy completedNCT02088775
What this trial is testing

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct Cancer+4 more
Fox Chase Cancer Center 44
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Early research (Phase 1)UnknownNCT04665362
What this trial is testing

IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC

Who this might be right for
Advanced/Metastatic Hepatocellular Carcinoma
Liang Peng 10
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Looking for participantsNCT07219459
What this trial is testing

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

Who this might be right for
Unresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
CatalYm GmbH 104
Next Page